Moderate Evidence
Research Overview
Follistatin Research for Age-Related Muscle Loss
An evidence-based overview of research examining Follistatin in the context of age-related muscle loss. This page synthesizes findings from peer-reviewed literature.
Research Summary
Follistatin overexpression improved neuromuscular junction innervation in aged mice. The combination of myostatin inhibition and NMJ improvement suggests potential for sarcopenia, but human evidence is absent for injectable forms.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Age-Related Muscle Loss
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Follistatin may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.